(Q59694044)
Statements
Impaired CD163-mediated hemoglobin-scavenging and severe toxic symptoms in patients treated with gemtuzumab ozogamicin (English)
Maciej Bogdan Maniecki
Birgitte Lausen
Ove Juul Nielsen
article
No description defined